1 enrolling by invitation. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Children: new trials by email Literature Review of Children trials Research Report on Children
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell Lymphoma Nivolumab - Primary Mediastinal (Thymic) Large B-cell Lymphoma, Children | Phase 1 / Phase 2 | Enrolling by invitation | St. Petersburg State Pavlov Medical University | 22 | 2024-09-01 | 2025-03-11 |
Cyclophosphamide (1) · Doxorubicin (1) · Etoposide (1) · Nivolumab (1) · Prednisolone (1) · Rituximab (1) · Vincristine (1)
St. Petersburg State Pavlov Medical University (1)
Russia (1)
Ludmila Zubarovskaya (1) · Natalya Myakova (1)